Konrad Wysocki

Konrad Wysocki is a senior markets reporter at Bez-kabli.pl, specializing in technology stocks, artificial intelligence and global financial markets. A graduate of the University of Rzeszów, he previously worked in investment research and market analysis. His coverage helps readers understand the key trends, companies and innovations influencing investors worldwide.

Phibro Animal Health Up 10% After Insider Move

Phibro Animal Health Up 10% After Insider Move

Phibro Animal Health Corp shares climbed over 10% on Wednesday after a director bought shares on the open market in the wake of a recent drop. The move put the stock ahead of the wider market. Phibro shares jumped 10.3% to $31.45 on the Nasdaq during afternoon trading. The stock earlier reached $31.67. Latest data put the company’s market value at around $1.29 billion.
June 3, 2026
Interlink Electronics Shares Fall Midday

Interlink Electronics Shares Fall Midday

Interlink Electronics shares dropped almost 8% in light Nasdaq action Wednesday. The Fremont, California-based sensor maker didn’t put out new company news to drive the fall. LINK’s slide is notable as it’s a micro-cap, meaning it has a small public-market value and its price can shift on light trading. The company’s total market cap was around $77.5 million.
June 3, 2026
Sallie Mae Hovers Near $22 Ahead of Major Loan Test

Sallie Mae Hovers Near $22 Ahead of Major Loan Test

SLM Corp. stock hovered near $22.05 in premarket trading Wednesday, with little move as investors got no new jolt from earnings. Focus stayed on the company’s push in graduate loans, the timing for its dividend, and credit conditions. The Nasdaq operated on a regular schedule—June 3 is not a market holiday in 2026, per Nasdaq. Sallie Mae is in focus now as private student-loan demand and consumer credit quality both remain hot topics. U.S. futures were divided early Wednesday—S&P 500 and Dow futures pointed lower, but Nasdaq 100 futures saw small gains. Smaller financials didn’t get much support from the market backdrop.
June 3, 2026
AN2 Therapeutics Shares Slip; Pipeline Update Due This Week May Be Next Driver

AN2 Therapeutics Shares Slip; Pipeline Update Due This Week May Be Next Driver

AN2 Therapeutics Inc shares ended at $4.07, slipping about 3% in the last session. Investors are waiting for CEO Eric Easom’s talk at the Jefferies Global Healthcare Conference this Thursday. The Nasdaq biotech had a market cap near $139 million before the U.S. open. The timing is notable. AN2 said Chief Executive Eric Easom is set to present June 4 at 12:50 p.m. ET. That puts management in front of investors soon, with a chance to update on the pipeline, which covers blood disease, infectious disease and early oncology.
June 3, 2026
Baiya’s 90-cent Nasdaq shares watch CEO handover as board shifts

Baiya’s 90-cent Nasdaq shares watch CEO handover as board shifts

Baiya International Group Inc. shares slid in U.S. pre-market trading Wednesday after the China-based HR tech firm revealed a leadership shakeup earlier this week. The stock, listed on Nasdaq, traded at $0.9009 in pre-market, off roughly 2.2% from Tuesday’s close. The main Nasdaq session opens at 9:30 a.m. and closes at 4 p.m. Eastern, but pre-market begins at 4 a.m. Moves can swing wider in that thin early trading, when there are fewer trades.
June 3, 2026
YHN Acquisition Stock Flat; Eyes on June Finish

YHN Acquisition Stock Flat; Eyes on June Finish

Shares of YHN Acquisition I Limited were flat ahead of Wednesday’s regular trading on Nasdaq. The small SPAC’s stock stayed close to trust value, with investors waiting for June, when its pending deal with Mingde Technology hits deadline. The stock was last at $10.83, up 6 cents from the last close, and valued the company at about $46.4 million, according to market data. The most recent trade came at 20:15 UTC on Tuesday, following the regular Nasdaq session.
June 3, 2026
Academy Sports Shares Could Move 8% Next Week as Wall Street Eyes Key Figure

Academy Sports Shares Could Move 8% Next Week as Wall Street Eyes Key Figure

Academy Sports and Outdoors shares slid Tuesday with traders looking ahead to next week’s fiscal Q1 results. The stock dropped about 2.3% to $51.38, after hitting a session low of $50.85. Options markets showed an implied move of 8.2% for the report due before the bell June 9, according to Bloomberg data cited by Investing.com. June 9 is in focus as Academy's spring sales got a bounce, but now the question is if that will show up in earnings. Analysts polled by Benzinga are looking for EPS at 94 cents, revenue at $1.44 billion. EPS stands for profit per share.
June 3, 2026
TRG Latin America Stock Quiet at $10 Mark as Activity Stalls

TRG Latin America Stock Quiet at $10 Mark as Activity Stalls

TRG Latin America Acquisitions Corp. shares didn’t trade on Nasdaq Tuesday, staying at $9.87 on Robinhood as of June 2. Volume stayed at zero for the session, leaving the blank-check company quiet as it seeks a merger. A different feed listed a $9.90 quote, but the last trade was May 28. That’s important now since TRG Latin America isn’t an operating company. It’s a special purpose acquisition company, or SPAC—a listed shell that collects cash and looks to buy a private firm. The stock tends to trade more on trust value, deal expectations and liquidity than on earnings.
June 2, 2026
Neuronetics Stock Drops As Traders Watch New TMS Research Effort

Neuronetics Stock Drops As Traders Watch New TMS Research Effort

Neuronetics Inc. dropped 5.7% to $1.575 Tuesday. This comes after the company announced that new NeuroStar data will be presented this week at a big transcranial magnetic stimulation conference. NEUR opened at $1.67, hit $1.76 before slipping to around $1.57, with volume near 785,000 shares. Timing is key here. Neuronetics wants to prove its NeuroStar system has stronger evidence behind it, even as the company deals with a balance-sheet crunch. Transcranial magnetic stimulation, or TMS, is a non-invasive therapy that uses magnetic pulses on specific brain regions, usually for patients whose depression hasn’t responded to medication.
June 2, 2026
Option Care Health Shares Edge Higher, Market Focuses on Outlook

Option Care Health Shares Edge Higher, Market Focuses on Outlook

Option Care Health ticked just above flat Tuesday afternoon after the home-infusion provider said it was ranked No. 15 on TIME’s 2026 list of the world’s most impactful companies. The stock traded 0.1% higher at $20.49, volume near 528,000 shares. It moved between $20.21 and $20.64. The QQQ ETF, which tracks the Nasdaq, gained 0.4%. Health Care Select Sector SPDR Fund, which covers the sector, slipped 1.1%.
June 2, 2026
Vendome Shares Hold Steady, Focus Shifts to $205.6 Million Trust

Vendome Shares Hold Steady, Focus Shifts to $205.6 Million Trust

Vendome Acquisition Corporation I stock was flat at $10.19 early Tuesday afternoon. Shares hovered near the usual cash trust price for SPACs waiting to announce a deal. As of 1:04 p.m. EDT, VNME was unchanged on the Nasdaq, according to StockAnalysis. That’s important now since Vendome is still a special purpose acquisition company, or SPAC—a listed shell company that raises cash first, then looks for a merger. For stocks like these, short-term focus stays on the trust account, redemption price, and the time the sponsor has left to make a deal, rather than sales or margins.
June 2, 2026
TON Strategy Shares Flat as Toncoin’s Gram Catches Traders Off Guard

TON Strategy Shares Flat as Toncoin’s Gram Catches Traders Off Guard

TON Strategy Company fell 1.4% to $4.17 on the Nasdaq late Tuesday morning, missing out on a big move higher in Toncoin. Telegram founder Pavel Durov announced the TON token will be renamed Gram. Shares ranged from $4.17 to $4.44, with volume at about 123,500 just after 11 a.m. EDT. Durov said “TON’s native currency is becoming Gram,” according to The Defiant. The token swap will take about three weeks and bring back the Gram name from TON’s first Telegram-linked white paper, The Defiant said.
June 2, 2026
New Providence trades flat as spotlight stays on Abra’s $750 million SPAC effort

New Providence trades flat as spotlight stays on Abra’s $750 million SPAC effort

New Providence Acquisition Corp. III shares stayed flat in early U.S. trade Tuesday. The SPAC kept close to its redemption value as investors looked for more details on the planned merger with Abra Financial Holdings. The Class A stock last traded at $10.35, off less than a cent, with just 19 shares changing hands as of about 10:05 a.m. in New York. Market cap stood at roughly $397.3 million.
June 2, 2026
IceCure Stock Drops Before The Bell As Nasdaq’s $1 Clock Ticks

IceCure Stock Drops Before The Bell As Nasdaq’s $1 Clock Ticks

IceCure Medical Ltd shares slipped in early U.S. pre-market trading on Tuesday, leaving the Nasdaq-listed medical device maker near 20 cents and still well below the exchange’s $1 minimum bid threshold. The stock last traded at $0.2011, down 1.9 cents, or about 8.6%, from its previous close. That is why the move matters now. IceCure said in May it received a second 180-day period, until Nov. 9, 2026, to regain compliance with Nasdaq’s minimum bid price rule. The company said it would need its closing bid price — the price buyers are willing to pay — to stay at or above $1 for at least 10 straight business days, and said a reverse split, which consolidates shares to lift the
June 2, 2026
DoubleDown Buyout Spread Draws Attention

DoubleDown Buyout Spread Draws Attention

DoubleDown Interactive Co., Ltd. shares barely moved in U.S. premarket trading Tuesday. The stock stayed above the all-cash offer from DoubleU Games, its controlling shareholder, which has set the reference point for recent trading. ADSs closed at $11.75, gaining 5 cents, or 0.4%. Shares are now about 50 cents above DoubleU Games’ $11.25-per-ADS offer, leaving a narrow gap as investors keep an eye on the company’s special committee.
June 2, 2026
Capricor Shares Fall, FDA Call in August Looms

Capricor Shares Fall, FDA Call in August Looms

Capricor Therapeutics shares moved lower in early trading Tuesday, following a 4.8% decline in the regular session. The rare-disease biotech is trading near $28.53 before the bell, as the stock stays focused on its looming U.S. regulatory date, not the broader market rally. Capricor’s current market value stands at around $1.64 billion. Capricor isn’t trading like a typical small-cap biotech anymore. Its valuation is tied to deramiocel, its experimental cell therapy for Duchenne muscular dystrophy, and the decision from the U.S. Food and Drug Administration, due by Aug. 22.
June 2, 2026
Nasdaq Filing Deadline Bears Down on Richtech Robotics Stock

Nasdaq Filing Deadline Bears Down on Richtech Robotics Stock

Richtech Robotics shares moved up about 2.5% to $3.10 in early U.S. trading Tuesday, with investors watching the delayed quarterly report and a looming Nasdaq compliance cutoff. Timing is key here. Richtech, a small-cap robotics play on Nasdaq, is pitching a recurring-revenue automation model to investors, but its March-quarter Form 10-Q filing with the SEC is still missing.
June 2, 2026
ROAD Slides Pre-Market as Construction Partners Confronts Oil Price Issue

ROAD Slides Pre-Market as Construction Partners Confronts Oil Price Issue

Construction Partners Inc. traded almost unchanged in early Tuesday action, sitting at $114.73 according to Google Finance, after closing Monday at $114.74, down 1.49%. The road builder dropped Monday as traders considered higher oil-linked costs and a backlog that remains strong. The timing is notable since there hasn’t been any new company release or SEC filing to move the story. The investor-relations page for Construction Partners still showed its most recent news was the May 8 fiscal Q2 report. The most recent 10-Q and 8-K filings were also dated May 8.
June 2, 2026
Fastly Gains 7% as AI Push Heads for Wall Street Test

Fastly Gains 7% as AI Push Heads for Wall Street Test

Fastly Inc. shares rallied Monday, bouncing with other software and internet-infrastructure stocks. Investors looked to a management update and circled back on the company's AI-traffic angle. The stock was last at $19.08, up $1.31, or 7.3%. The session high was $19.46. Volume reached 8.1 million shares, bringing the company’s market cap to about $2.93 billion.
June 1, 2026
1 24 25 26 27 28 54